trial
as of 2026-07-01A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia
NCTId NCT07011953
at a glance
Early Phase 1 · Not Yet Recruiting
Enrollment 90 (estimated)
Sponsored by Peking University
Primary completion 2027-07-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Early Phase 1
Status
Not Yet Recruiting
Enrollment
90 (estimated)
Study type
Interventional
Allocation
Na
Model
Parallel
Masking
Quadruple
Start
2025-07-01
Primary completion
2027-07-01
Eligibility
ALL · 18 Years · 45 Years
Interventions & indications
Sponsors
Peking UniversityLead Sponsor
Sites
0 total
Facts & assertions
4 sourced
Enrollment
90
Phase
EARLY_PHASE1
Primary Completion Date
2027-07-01
Status
NOT_YET_RECRUITING
relationships
The graph out of here
lead_sponsor
company
indication